These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 23220257)

  • 21. Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity.
    Kumar P; Kalonia H; Kumar A
    Life Sci; 2009 Nov; 85(19-20):711-8. PubMed ID: 19822156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ-SLNs) on 3-nitroproponic acid induced Huntington's disease-like symptoms in wistar rats.
    Ramachandran S; Thangarajan S
    Chem Biol Interact; 2016 Aug; 256():25-36. PubMed ID: 27206696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Striatal mitochondria response to 3-nitropropionic acid and fish oil treatment.
    Orozco-Ibarra M; García-Morales J; Calvo-Silva FJ; Fernández-Valverde F; Serrano-García N
    Nutr Neurosci; 2018 Feb; 21(2):132-142. PubMed ID: 27682807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levothyroxine attenuates behavioral impairment and improves oxidative stress and histological alteration 3-nitropropionic acid induced experimental Huntington's disease in rats.
    Badini F; Bayrami A; Mirshekar MA; Shahraki S; Fanaei H
    Behav Brain Res; 2024 Mar; 461():114864. PubMed ID: 38220060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction.
    Mehan S; Monga V; Rani M; Dudi R; Ghimire K
    Indian J Pharmacol; 2018; 50(6):309-319. PubMed ID: 30783323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease.
    Gao Y; Chu SF; Li JP; Zhang Z; Yan JQ; Wen ZL; Xia CY; Mou Z; Wang ZZ; He WB; Guo XF; Wei GN; Chen NH
    Acta Pharmacol Sin; 2015 Mar; 36(3):311-22. PubMed ID: 25640478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective potential of antioxidant potent fractions from Convolvulus pluricaulis Chois. in 3-nitropropionic acid challenged rats.
    Kaur M; Prakash A; Kalia AN
    Nutr Neurosci; 2016; 19(2):70-8. PubMed ID: 25896328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-theanine, a Component of Green Tea Prevents 3-Nitropropionic Acid (3-NP)-Induced Striatal Toxicity by Modulating Nitric Oxide Pathway.
    Jamwal S; Kumar P
    Mol Neurobiol; 2017 Apr; 54(3):2327-2337. PubMed ID: 26957301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of phosphodiesterase-1 (PDE1) and ATP sensitive potassium (KATP) channel modulators against 3-nitropropionic acid induced behavioral and biochemical toxicities in experimental Huntington׳s disease.
    Gupta S; Sharma B
    Eur J Pharmacol; 2014 Jun; 732():111-22. PubMed ID: 24690258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of mGlu5 receptor in 3-nitropropionic acid-induced oxidative stress in rat striatum.
    Souza LC; Wilhelm EA; Bortolatto CF; Nogueira CW; Boeira SP; Jesse CR
    Neurol Res; 2014 Sep; 36(9):833-40. PubMed ID: 24588139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease.
    Pérez-De La Cruz V; Elinos-Calderón D; Robledo-Arratia Y; Medina-Campos ON; Pedraza-Chaverrí J; Ali SF; Santamaría A
    Behav Brain Res; 2009 May; 199(2):210-7. PubMed ID: 19100293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington's Disease.
    Chakraborty J; Singh R; Dutta D; Naskar A; Rajamma U; Mohanakumar KP
    CNS Neurosci Ther; 2014 Jan; 20(1):10-9. PubMed ID: 24188794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment with Bacopa monnieri extract offsets 3-nitropropionic acid induced mitochondrial oxidative stress and dysfunctions in the striatum of prepubertal mouse brain.
    Shinomol GK; Bharath MM; Muralidhara
    Can J Physiol Pharmacol; 2012 May; 90(5):595-606. PubMed ID: 22472017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial dysfunction, oxidative stress, ER stress and mitochondria-ER crosstalk alterations in a chemical rat model of Huntington's disease: Potential benefits of bezafibrate.
    Brondani M; Roginski AC; Ribeiro RT; de Medeiros MP; Hoffmann CIH; Wajner M; Leipnitz G; Seminotti B
    Toxicol Lett; 2023 May; 381():48-59. PubMed ID: 37116597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity.
    Kumar P; Kalonia H; Kumar A
    Eur J Pharmacol; 2012 Jan; 674(2-3):265-74. PubMed ID: 22154757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
    Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K
    Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced neuroprotective effect of fish oil in combination with quercetin against 3-nitropropionic acid induced oxidative stress in rat brain.
    Denny Joseph KM; Muralidhara
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():83-92. PubMed ID: 22960609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington's disease.
    Sharma P; Kumar M; Bansal N
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Sep; 394(9):1917-1928. PubMed ID: 34061228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats.
    Menze ET; Tadros MG; Abdel-Tawab AM; Khalifa AE
    Neurotoxicology; 2012 Oct; 33(5):1265-75. PubMed ID: 22850463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease.
    Bizat N; Hermel JM; Boyer F; Jacquard C; Créminon C; Ouary S; Escartin C; Hantraye P; Kajewski S; Brouillet E
    J Neurosci; 2003 Jun; 23(12):5020-30. PubMed ID: 12832525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.